Evidence map›Paper›PMID 38978392›Full record

ArticleJournal of the International AIDS Society2024

A cross-sectional assessment of injection of "salts" and HIV transmission-related behaviours among a cohort of people who inject drugs in Kyrgyzstan.

Rebecca Kennedy, Zachary Bouck, Dan Werb, Ainura Kurmanalieva, Anna Blyum, Natalya Shumskaya, Thomas L Patterson, Javier A Cepeda, Laramie R Smith

Abstract read
In one paragraph

Article in Journal of the International AIDS Society, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Rebecca KennedySchool of Medicine, University of California San Diego, La Jolla, California, USA.ORCID https://orcid.org/0000-0002-6575-3017
Zachary BouckCentre on Drug Policy Evaluation, Unity Health Toronto, Toronto, Ontario, Canada.
Dan WerbSchool of Medicine, University of California San Diego, La Jolla, California, USA.
Ainura KurmanalievaAIDS Foundation-East West in the Kyrgyz Republic, Bishkek, Kyrgyzstan.
Anna BlyumSchool of Medicine, University of California San Diego, La Jolla, California, USA.
Natalya ShumskayaAIDS Foundation-East West in the Kyrgyz Republic, Bishkek, Kyrgyzstan.
Thomas L PattersonDepartment of Psychiatry, University of California San Diego, La Jolla, California, USA.
Javier A CepedaBloomberg School of Public Health, Johns Hopkins University, Baltimore, Maryland, USA.ORCID https://orcid.org/0000-0003-0304-3172
Laramie R SmithSchool of Medicine, University of California San Diego, La Jolla, California, USA.ORCID https://orcid.org/0000-0002-5371-3229

Funding

VirologyP30AI036214 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI SONIA JAIN · 1994 to 2026
$78.4M
Addressing negative social experiences through coping and resilience to reduce methamphetamine use and improve PrEP cascade progression among Latino MSMK01DA055521 · NIDA · ARIZONA STATE UNIVERSITY-TEMPE CAMPUS · PI Angel B Algarin · 2022 to 2026
$943k
MODELING THE IMPACT OF A POLICE EDUCATION PROGRAM ON HIV INCIDENCE AMONG PEOPLE WHO INJECT DRUGSK01DA043421 · NIDA · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI CEPEDA, JAVIER · 2017 to 2021
$941k
Identifying Intersectional Stigma Intervention Targets for People Who Inject Drugs in a High-Risk International SettingR21TW011785 · FIC · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI SMITH, LARAMIE RAE · 2020 to 2021
$418k
CIHR CIHRPJH-175382FIC NIH HHS R21TW011785National Institutes of Health and Canadian Institutes of Health ResearchNIDA NIH HHS K01DA043421NIDA NIH HHS K01DA055521NIH HHS P30AI036214
6 · The paper itself

Abstract

introductionDespite the increasing availability of new psychoactive substances (hereafter referred to as "salts") in Eastern Europe and Central Asia, there is a dearth of epidemiological data on the relationship between injecting "salts" and HIV risk behaviours. This is particularly relevant in settings where injection drug use accounts for a substantial proportion of the HIV burden, such as in Kyrgyzstan, a former Soviet Republic. This study assessed whether injecting "salts" is associated with sexual and injection-related HIV risk behaviours among people who inject drugs in Kyrgyzstan.

methodsThe Kyrgyzstan InterSectional Stigma Study is a cohort of people who inject drugs in Kyrgyzstan's capital of Bishkek and the surrounding rural administrative division of Chuy Oblast. We conducted a cross-sectional analysis using survey data collected from cohort participants between July and November 2021, which included information on injection drug use (including "salts") and HIV risk behaviours. To minimize confounding by measured covariates, we used inverse-probability-weighted logistic and Poisson regression models to estimate associations between recent "salt" injection and HIV risk behaviours.

resultsOf 181 participants included in the analysis (80.7% men, 19.3% women), the mean age was 40.1 years (standard deviation [SD] = 8.8), and 22% (n = 39) reported that they had injected "salts" in the past 6 months. Among people who injected "salts," 72% (n = 28) were men, and most were ethnically Russian 59% (n = 23), with a mean age of 34.6 (SD = 9.6). Injecting "salts" was significantly associated with a greater number of injections per day (adjusted relative risk [aRR] = 1.59, 95% confidence interval [CI] = 1.30-1.95) but lower odds of using syringe service programmes in the past 6 months (adjusted odds ratio [aOR] = 0.20, 95% CI = 0.12-0.32). Injecting "salts" was also significantly associated with lower odds of condomless sex in the past 6 months (aOR = 0.42, 95% CI = 0.24-0.76) and greater odds of having ever heard of pre-exposure prophylaxis (aOR = 4.80, 95% CI = 2.61-8.83).

conclusions(PWID) people who inject drugs who inject "salts" are a potentially emergent group with increased HIV acquisition risk in Kyrgyzstan. Targeted outreach bundled with comprehensive harm reduction and pre-exposure prophylaxis services are needed to prevent transmission of HIV and other blood-borne viruses.

Indexed as

HIV InfectionsRisk-TakingSubstance Abuse, IntravenousAdolescentAdultCohort StudiesCross-Sectional StudiesFemaleHumansKyrgyzstanMaleMiddle AgedPsychotropic DrugsSexual BehaviorYoung AdultPsychotropic Drugsdrug useHIV preventionkey and vulnerable populationsPrEPpublic healthrisk factors

Identifiers

PMID38978392
PMCPMC11231446

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.